Skip to main content
logo
Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
41.30
+0.10 (0.24%)
Aug 4, 2026, 12:54 PM CST

TPEX:6864 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.710.710.610.732.70.09
Revenue Growth
22.78%15.36%-15.93%-73.01%2964.77%20.55%
Gross Profit
0.330.330.140.331.290.05
Operating Income
-95.99-95.99-76.48-59.91-43.37-28.31
Net Income
-93.6-93.6-74.52-51.78-31.74-22.35
Earnings Per Share
-2.88-2.88-2.46-2.07-1.27-1.19
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
466.22466.22194.1378.43131.11166.58
Total Debt
1.231.232.391.383.9913.31
Net Cash (Debt)
464.99464.99191.7477.04127.13153.27
Net Cash Growth
142.51%142.51%148.87%-39.40%-17.06%73.60%
Net Cash Per Share
14.3114.316.333.085.098.16

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-77.73-77.73-64.15-48.26-30.66-20.13
Capital Expenditures
-6.81-6.81-8.37-1.52-7.74-3.29
Free Cash Flow
-84.53-84.53-72.52-49.78-38.41-23.41
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
46.18%46.18%23.53%45.19%47.91%53.41%
Operating Margin
-13595.61%-13595.61%-12496.24%-8228.85%-1608.12%-32164.77%
Pretax Margin
-13257.37%-13257.37%-12175.98%-7800.96%-1475.97%-31029.55%
Profit Margin
-13257.36%-13257.36%-12175.98%-7112.91%-1176.75%-25398.86%
FCF Margin
-11973.09%-11973.09%-11850.00%-6837.78%-1424.03%-26606.82%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2249.903972.373218.63870.54284.1115909.09